Osteoprotegerin (OPG) Expression by Breast Cancer Cells in vitro and Breast Tumours in vivo – A Role in Tumour Cell Survival?

@article{Holen2005OsteoprotegerinE,
  title={Osteoprotegerin (OPG) Expression by Breast Cancer Cells in vitro and Breast Tumours in vivo – A Role in Tumour Cell Survival?},
  author={Ingunn Holen and Simon S. Cross and Helen L. Neville-Webbe and Neil Alan Cross and Sabapathy Prakash Balasubramanian and Peter Ian Croucher and C. Alyson Evans and Jennifer M. Lippitt and Robert Coleman and Colby L. Eaton},
  journal={Breast Cancer Research and Treatment},
  year={2005},
  volume={92},
  pages={207-215}
}
In addition to its role in bone turnover, osteoprotegerin (OPG) has been reported to bind to and inhibit Tumour necrosis factor-related apoptosis inducing ligand (TRAIL). TRAIL is produced in tumours by invading monocytes, inducing apoptosis in neoplastic cells sensitive to this cytokine. OPG production by tumour cells would therefore be a novel mechanism whereby cancer cells evade host defences and gain a growth advantage. In this study we show that OPG produced by breast cancer cells enhances… CONTINUE READING
54 Citations
32 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 54 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Lopez-Rivas A: Interferongamma treatment elevates caspase-8 expression and sensitises human breast cancer cells to a death receptor-induced mitochondria-operated apoptotic program

  • C Ruiz-Ruiz, C Munoz-Pinedo
  • Cancer Res
  • 2000
Highly Influential
4 Excerpts

Differential gene expression of TGF-beta family members and osteopontin in breast tumour tissue: analysis by real-time quantitative PCR

  • MM Reinholz, SJ Iturria, PC Roche
  • Breast Cancer Res Treat
  • 2002
1 Excerpt

Similar Papers

Loading similar papers…